Reliant Investment Partners’s Eli Lilly LLY Stock Holding History

Reliant Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.72M	Sell	3,098 -46	-1%	-$47K	2.53%	7
2026 Q1	$2.89M	Sell	3,144 -8	-0.3%	-$8.11K	2.4%	8
2025 Q4	$3.39M	Sell	3,152 -13	-0.4%	-$12.4K	2.66%	9
2025 Q3	$2.66M	Sell	3,165 -7	-0.2%	-$5.21K	2.08%	10
2025 Q2	$2.47M	Sell	3,172 -9	-0.3%	-$6.99K	2.16%	11
2025 Q1	$2.63M	Sell	3,181 -26	-0.8%	-$21.6K	2.68%	9
2024 Q4	$2.48M	Buy	+3,207	New	+$2.66M	2.19%	11

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Reliant Investment Partners's LLY Position: Q2 2026 in Review

Reliant Investment Partners reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2026, selling an estimated $47K and leaving 3,098 shares worth $3.72M. The position accounts for 2.53% of the portfolio, ranked #7.

Reliant Investment Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Reliant Investment Partners held 3,098 shares of Eli Lilly worth $3.72M as of Q2 2026.
Reliant Investment Partners sold 46 Eli Lilly shares in Q2 2026, an estimated $47K.
Eli Lilly made up 2.53% of Reliant Investment Partners's portfolio in Q2 2026, its #7 holding.
Reliant Investment Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Reliant Investment Partners's 13F filing for Q2 2026, filed 11 Aug 2026.